blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3854403

EP3854403 - USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  28.07.2023
Database last updated on 22.01.2025
FormerRequest for examination was made
Status updated on  04.02.2022
FormerThe application has been published
Status updated on  25.06.2021
Most recent event   Tooltip30.09.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Academy of Military Medical Sciences
No. 27 Taiping Road
Haidian District
Beijing 100850 / CN
[2021/30]
Inventor(s)01 / ZHONG, Wu
NO.27,TAIPING ROAD HAIDIAN DISTRICT
BEIJING, 100850 / CN
02 / CAO, Ruiyuan
NO.27,TAIPING ROAD HAIDIAN DISTRICT
BEIJING, 100850 / CN
03 / XIAO, Gengfu
NO.27,TAIPING ROAD HAIDIAN DISTRICT
BEIJING, 100850 / CN
04 / HU, Zhihong
NO.27,TAIPING ROAD HAIDIAN DISTRICT
BEIJING, 100850 / CN
05 / WANG, Manli
NO.27,TAIPING ROAD HAIDIAN DISTRICT
BEIJING, 100850 / CN
06 / ZHANG, Leike
NO.27,TAIPING ROAD HAIDIAN DISTRICT
BEIJING, 100850 / CN
07 / LI, Wei
NO.27,TAIPING ROAD HAIDIAN DISTRICT
BEIJING, 100850 / CN
08 / LI, Yuexiang
NO.27,TAIPING ROAD HAIDIAN DISTRICT
BEIJING, 100850 / CN
09 / ZHAO, Lei
NO.27,TAIPING ROAD HAIDIAN DISTRICT
BEIJING, 100850 / CN
10 / FAN, Shiyong
NO.27,TAIPING ROAD HAIDIAN DISTRICT
BEIJING, 100850 / CN
11 / LI, Song
NO.27,TAIPING ROAD HAIDIAN DISTRICT
BEIJING, 100850 / CN
 [2021/30]
Representative(s)Lavoix
Bayerstraße 83
80335 München / DE
[2021/30]
Application number, filing date20202229.916.10.2020
[2021/30]
Priority number, dateCN2020107108721.01.2020         Original published format: CN202010071087
[2021/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3854403
Date:28.07.2021
Language:EN
[2021/30]
Search report(s)(Supplementary) European search report - dispatched on:EP12.04.2021
ClassificationIPC:A61K31/685, A61P31/14, A61P11/00
[2021/30]
CPC:
A61K31/685 (EP,EA,US); A61K31/675 (CN); A61P11/00 (EP,CN);
A61P31/14 (EP,CN,EA,US); C07F9/6561 (CN)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/10]
Former [2021/30]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:VERWENDUNG VON SUBSTITUIERTEN AMINOPROPIONSÄUREVERBINDUNGEN ZUR BEHANDLUNG VON SARS-COV-2-INFEKTION[2021/30]
English:USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION[2021/30]
French:UTILISATION DE COMPOSÉS D'AMINOPROPIONATE SUBSTITUÉS DANS LE TRAITEMENT DE L'INFECTION SARS-COV-2[2021/30]
Examination procedure27.01.2022Examination requested  [2022/10]
27.01.2022Date on which the examining division has become responsible
05.04.2022Amendment by applicant (claims and/or description)
31.07.2023Despatch of a communication from the examining division (Time limit: M04)
19.10.2023Reply to a communication from the examining division
Fees paidRenewal fee
28.10.2022Renewal fee patent year 03
30.10.2023Renewal fee patent year 04
30.09.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]WO2017049060  (GILEAD SCIENCES INC [US]) [X] 1,2,11-13,15 * paragraph [0400]; figures 1-4; examples 40-46; claims 39,61-63,65-74 * * page 0134 * [I] 1-15;
 [XI]  - Anonymous, "Gillings research on broad-spectrum antiviral could aid public health response to coronavirus outbreaks - UNC Gillings School of Global Public Health", (20200110), URL: https://sph.unc.edu/sph-news/gillings-research-on-broad-spectrum-antiviral-could-aid-public-health-response-to-coronavirus-outbreaks/, (20210308), XP055782994 [X] 1,2,15 * the whole document * [I] 1-15
 [XI]  - Nature Portfolio Microbiology Community, "Preparing for future pandemics, today with broad-spectrum antivirals | Nature Portfolio Microbiology Community", (20200110), URL: https://naturemicrobiologycommunity.nature.com/posts/58125-preparing-for-future-pandemics-today-with-broad-spectrum-antivirals, (20210308), XP055783036 [X] 1,2,15 * the whole document * [I] 1-15
 [XI]  - SHEAHAN TIMOTHY P. ET AL, "Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses", SCIENCE TRANSLATIONAL MEDICINE, US, (20170628), vol. 9, no. 396, doi:10.1126/scitranslmed.aal3653, ISSN 1946-6234, page eaal3653, XP055783008 [X] 1,2,11-13,15 * abstract * [I] 1-15

DOI:   http://dx.doi.org/10.1126/scitranslmed.aal3653
 [XI]  - MARIA L. AGOSTINI ET AL, "Coronavirus Susceptibility to the Antiviral Remdesivir (GS5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease", MBIO, (20180306), vol. 9, no. 2, doi:10.1128/mBio.00221-18, pages 1 - 15, XP055677700 [X] 1,2,15 * abstract * [I] 1-15

DOI:   http://dx.doi.org/10.1128/mBio.00221-18
 [XI]  - ALLISON L. TOTURA ET AL, "Broad-spectrum coronavirus antiviral drug discovery", EXPERT OPINION ON DRUG DISCOVERY, London, GB, (20190308), vol. 14, no. 4, doi:10.1080/17460441.2019.1581171, ISSN 1746-0441, pages 397 - 412, XP055677701 [X] 1,2,15 * page 404, column r, paragraph l - page 405, column l, paragraph f * [I] 1-15

DOI:   http://dx.doi.org/10.1080/17460441.2019.1581171
by applicantCN20201071087
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.